9.72 USD
+0.13 (+1.36%)
At close: Feb 6, 2026
9.72 USD
0 (0%)
After Hours: 2/6/2026, 8:00:02 PM
JYNT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. JYNT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. JYNT has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- In the past year JYNT has reported negative net income.
- JYNT had a positive operating cash flow in the past year.
- In multiple years JYNT reported negative net income over the last 5 years.
- JYNT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -1.40%, JYNT is in line with its industry, outperforming 44.12% of the companies in the same industry.
- JYNT's Return On Equity of -4.27% is in line compared to the rest of the industry. JYNT outperforms 47.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.4% | ||
| ROE | -4.27% | ||
| ROIC | N/A |
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Gross Margin, with a value of 78.26%, JYNT belongs to the top of the industry, outperforming 93.14% of the companies in the same industry.
- In the last couple of years the Gross Margin of JYNT has declined.
- JYNT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 78.26% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
2. Health
2.1 Basic Checks
- JYNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
- JYNT has more shares outstanding than it did 1 year ago.
- JYNT has more shares outstanding than it did 5 years ago.
- JYNT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- JYNT has an Altman-Z score of 2.95. This is not the best score and indicates that JYNT is in the grey zone with still only limited risk for bankruptcy at the moment.
- JYNT's Altman-Z score of 2.95 is fine compared to the rest of the industry. JYNT outperforms 63.73% of its industry peers.
- JYNT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 2.95 |
ROIC/WACCN/A
WACC8.84%
2.3 Liquidity
- A Current Ratio of 1.83 indicates that JYNT should not have too much problems paying its short term obligations.
- JYNT has a Current ratio of 1.83. This is in the better half of the industry: JYNT outperforms 72.55% of its industry peers.
- A Quick Ratio of 1.83 indicates that JYNT should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.83, JYNT is in the better half of the industry, outperforming 75.49% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.83 | ||
| Quick Ratio | 1.83 |
3. Growth
3.1 Past
- JYNT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 99.03%, which is quite impressive.
- The Revenue for JYNT has decreased by -24.15% in the past year. This is quite bad
- Measured over the past years, JYNT shows a small growth in Revenue. The Revenue has been growing by 1.36% on average per year.
EPS 1Y (TTM)99.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.52%
Revenue 1Y (TTM)-24.15%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-55.69%
3.2 Future
- JYNT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 44.54% yearly.
- The Revenue is expected to decrease by -22.13% on average over the next years. This is quite bad
EPS Next Y83%
EPS Next 2Y95.15%
EPS Next 3Y44.54%
EPS Next 5YN/A
Revenue Next Year-54.9%
Revenue Next 2Y-31.56%
Revenue Next 3Y-22.13%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for JYNT. In the last year negative earnings were reported.
- The Price/Forward Earnings ratio is 24.43, which indicates a rather expensive current valuation of JYNT.
- The rest of the industry has a similar Price/Forward Earnings ratio as JYNT.
- The average S&P500 Price/Forward Earnings ratio is at 27.78. JYNT is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 24.43 |
4.2 Price Multiples
- The rest of the industry has a similar Price/Free Cash Flow ratio as JYNT.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 88.54 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- JYNT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- JYNT's earnings are expected to grow with 44.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y95.15%
EPS Next 3Y44.54%
5. Dividend
5.1 Amount
- No dividends for JYNT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
9.72
+0.13 (+1.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)03-11 2026-03-11/amc
Inst Owners78.47%
Inst Owner Change-0.53%
Ins Owners22.97%
Ins Owner Change2.68%
Market Cap144.54M
Revenue(TTM)91.63M
Net Income(TTM)-970.20K
Analysts76
Price Target10.88 (11.93%)
Short Float %8.53%
Short Ratio10.49
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.07%
Min Revenue beat(2)-2.34%
Max Revenue beat(2)-1.81%
Revenue beat(4)0
Avg Revenue beat(4)-14.21%
Min Revenue beat(4)-51.14%
Max Revenue beat(4)-1.53%
Revenue beat(8)3
Avg Revenue beat(8)-6.24%
Revenue beat(12)3
Avg Revenue beat(12)-4.83%
Revenue beat(16)5
Avg Revenue beat(16)-4.04%
PT rev (1m)-0.77%
PT rev (3m)-28.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-54.29%
EPS NY rev (1m)-12.83%
EPS NY rev (3m)-1366.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.2%
Revenue NY rev (1m)-0.44%
Revenue NY rev (3m)-1.91%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 24.43 | ||
| P/S | 1.58 | ||
| P/FCF | 88.54 | ||
| P/OCF | 47.06 | ||
| P/B | 6.37 | ||
| P/tB | 6.37 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.01
EYN/A
EPS(NY)0.4
Fwd EY4.09%
FCF(TTM)0.11
FCFY1.13%
OCF(TTM)0.21
OCFY2.12%
SpS6.16
BVpS1.53
TBVpS1.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.4% | ||
| ROE | -4.27% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 78.26% | ||
| FCFM | 1.78% |
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
F-Score6
Asset Turnover1.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 78.79% | ||
| Cap/Sales | 1.57% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.83 | ||
| Quick Ratio | 1.83 | ||
| Altman-Z | 2.95 |
F-Score6
WACC8.84%
ROIC/WACCN/A
Cap/Depr(3y)57.36%
Cap/Depr(5y)93.23%
Cap/Sales(3y)6.25%
Cap/Sales(5y)6.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.52%
EPS Next Y83%
EPS Next 2Y95.15%
EPS Next 3Y44.54%
EPS Next 5YN/A
Revenue 1Y (TTM)-24.15%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-55.69%
Revenue Next Year-54.9%
Revenue Next 2Y-31.56%
Revenue Next 3Y-22.13%
Revenue Next 5YN/A
EBIT growth 1Y-575.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year312.75%
EBIT Next 3Y60.95%
EBIT Next 5YN/A
FCF growth 1Y-85.24%
FCF growth 3Y6.31%
FCF growth 5Y15.29%
OCF growth 1Y-81.35%
OCF growth 3Y-12.05%
OCF growth 5Y4.6%
JOINT CORP/THE / JYNT FAQ
What is the ChartMill fundamental rating of JOINT CORP/THE (JYNT) stock?
ChartMill assigns a fundamental rating of 3 / 10 to JYNT.
Can you provide the valuation status for JOINT CORP/THE?
ChartMill assigns a valuation rating of 3 / 10 to JOINT CORP/THE (JYNT). This can be considered as Overvalued.
How profitable is JOINT CORP/THE (JYNT) stock?
JOINT CORP/THE (JYNT) has a profitability rating of 3 / 10.
How financially healthy is JOINT CORP/THE?
The financial health rating of JOINT CORP/THE (JYNT) is 6 / 10.